Back to Authors

Carpio, Lomeli R.

Mayo Clinic

Mayo Clinic

Citations 2

Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling
Carpio, Lomeli R., Bradley, Elizabeth W. , Weivoda, Megan , Poston, Daniel , Dudakovic, Amel , Xu, Ming , Tchkonia, Tamar , Kirkland, James L. , Wijnen, André J. van , Oursler, Merry Jo, Shull, Lomeli C. , Weivoda, Megan M, Poston, Daniel D, van Wijnen, Andre J, McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J. , van Wijnen, Andre J , Bradley, Elizabeth W , Xu, Ming , Tchkonia, T

Science Signaling | August 9, 2016 | Volume: 9 | Issue: 440 | Pages: No page available

10.1126/scisignal.aaf3273 Get It

Histone deacetylase 3 prevents chondrocytes from producing inflammatory mediators that prevent bone development.
Histone Deacetylases in Bone Development and Skeletal Disorders
Bradley, Elizabeth W. , Carpio, Lomeli R., Wijnen, André J. van , McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J., Shull, Lomeli C. , van Wijnen, Andre J, Westendorf, Jennifer J. , van Wijnen, Andre J , Bradley, Elizabeth W , McGee-Lawrence, Meghan E

Physiological Reviews | September 17, 2015 | Volume: 95 | Issue: 4 | Pages: 1359-1381

10.1152/physrev.00004.2015 Get It

Histone deacetylases (Hdacs) are conserved enzymes that remove acetyl groups from lysine side chains in histones and other proteins. Eleven of the 18 Hdacs encoded by the human and mouse genomes depend on Zn2+for enzymatic activity, while the other 7, the sirtuins (Sirts), require NAD2+. Collectively, Hdacs and Sirts regulate numerous cellular and mitochondrial processes including gene transcription, DNA repair, protein stability, cytoskeletal dynamics, and signaling pathways to affect both development and aging. Of clinical relevance, Hdacs inhibitors are United States Food and Drug Administration-approved cancer therapeutics and are candidate therapies for other common diseases including arthritis, diabetes, epilepsy, heart disease, HIV infection, neurodegeneration, and numerous aging-related disorders. Hdacs and Sirts influence skeletal development, maintenance of mineral density and bone strength by affecting intramembranous and endochondral ossification, as well as bone resorption. With few exceptions, inhibition of Hdac or Sirt activity though either loss-of-function mutations or prolonged chemical inhibition has negative and/or toxic effects on skeletal development and bone mineral density. Specifically, Hdac/Sirt suppression causes abnormalities in physiological development such as craniofacial dimorphisms, short stature, and bone fragility that are associated with several human syndromes or diseases. In contrast, activation of Sirts may protect the skeleton from aging and immobilization-related bone loss. This knowledge may prolong healthspan and prevent adverse events caused by epigenetic therapies that are entering the clinical realm at an unprecedented rate. In this review, we summarize the general properties of Hdacs/Sirts and the research that has revealed their essential functions in bone forming cells (e.g., osteoblasts and chondrocytes) and bone resorbing osteoclasts. Finally, we offer predictions on future research in this area and the utility of this knowledge for orthopedic applications and bone tissue engineering.